Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Positive crawled time : 08:20 save search
First Results with Erdafitinib-Releasing Intravesical Delivery System (TAR-210) Show Early Evidence of Positive Clinical Activity in Patients with Non-Muscle-Invasive Bladder Cancer with Select Fibroblast Growth Factor Receptor Alterations
Published: 2023-10-22 (Crawled : 08:20) - prnewswire.com
JNJ | News | $149.12 0.82% 0.59% 440K
|
Health Technology
| Email alert
Add to watchlist
tar-210 bladder positive cancer system results show growth
Olema Oncology Announces Positive Phase 2 Monotherapy Clinical Study Results for Palazestrant
Published: 2023-10-22 (Crawled : 08:20) - globenewswire.com
OLMA | $9.87 -0.6% -0.61% 810K
|
Health Technology
| Email alert
Add to watchlist
positive results study phase 2
Acumen Pharmaceuticals Presents Positive Topline Results from First-in-Human Phase 1 Study of ACU193 for Early Alzheimer’s Disease at the Alzheimer’s Association International Conference (AAIC) 2023
Published: 2023-07-16 (Crawled : 08:20) - globenewswire.com
ABOS | $3.13 -0.64% -0.48% 31
|
Professional, Scientific, and T...
| Email alert
Add to watchlist
acu193 conference disease association alzheimer’s positive international pharmaceuticals topline results study
Positive Phase 2 Data from RAPIDe-1 Study of PHVS416 for the On-Demand Treatment of HAE Attacks Highlighted at the 2023 HAEi Regional Conference APAC
Published: 2023-03-18 (Crawled : 08:20) - globenewswire.com
PHVS | $20.87 8.92% 7.39% 51K
|
| Email alert
Add to watchlist
phvs416 conference positive treatment study
Positive Initial Clinical Data from the B-LIEVE Dose-Confirmation Trial for FLT180a in Hemophilia B Presented at the International Society on Thrombosis and Haemostasis Congress
Published: 2022-07-10 (Crawled : 08:20) - globenewswire.com
FRLN | $6.48 0.0% 0
|
Health Technology
| Email alert
Add to watchlist
flt180 trial positive international
pep+ (PEPSICO POSITIVE) TAKES CENTER STAGE AT EXPO 2020 DUBAI OPENING DAY
Published: 2021-10-02 (Crawled : 08:20) - prnewswire.com
PEP | $176.46 1.34% 1.33% 230K
|
Consumer Non-Durables
| Email alert
Add to watchlist
positive
Merrimack Pharmaceuticals Announces Initiation of a Phase 2 Biomarker-Selected Clinical Trial of MM-121 in Patients with Heregulin Positive Non-Small Cell Lung Cancer
Published: 2015-02-19 (Crawled : 08:20) - globenewswire.com
MACK 4 | $14.73 0.07% 0.2% 95K
|
Health Technology
| Email alert
Add to watchlist
phase 2 lung cancer positive cancer trial mm-120 biomarkers
Gainers vs Losers
| 72% | 28% |
Top 10 Gainers
AGBA | $2.5 100.0% 58.33% 200M
|
Finance
EDBL | News | $6.26 66.49% 48.56% 270K
|
SMFL | $4.35 29.2% 47.55% 4.2M
|
Manufacturing
MLEC | $2.47 76.43% 38.05% 460K
|
n/a
PEGY | $0.0458 -10.2% 28.77% 79M
|
Manufacturing
PROK | $2.72 33.33% 26.88% 20K
|
PALI | $4.93 4.67% 25.83% 2.1M
|
Manufacturing
SGD | $0.685 -1.71% 22.48% 2M
|
n/a
SILO | $1.99 0.71% 20.64% 1.8M
|
Finance and Insurance
NNVC | $1.12 1.82% 19.64% 2.5K
|
Health Technology
Your saved searches
Save your searches and get alerts when important news are released.